Health care costs
CVD cost the health care system in the UK around £14.4 billion in 2006. This represents a cost per capita of just under £250. The cost of hospital care for people who have CVD accounts for about 72% of these costs, whereas 20% of the cost is due to drugs.
CHD cost the health care system in the UK around £3.2 billion in 2006 and stroke cost approximately the same amount. This represents a cost per capita of just over £50 for each condition. The cost of hospital care for people who have CHD accounts for about 73% of these costs. The hospital costs for stroke account for 94% of the total health care costs.
Non-health care costs
Looking only at the health care costs of CVD grossly underestimates the total cost of CVD in the UK. Production losses from death and illness in those of working age and from the informal care of people with the disease contribute greatly to the overall financial burden.
In 2006, production losses due to mortality and morbidity associated with CVD cost the UK over £8.2 billion, with around 55% of this cost due to death and 45% due to illness in those of working age. The cost of informal care for people with CVD in the UK was over £8.0 billion3 in 2006.
In 2006, production losses due to mortality and morbidity associated with CHD cost the UK over £3.9 billion, with around 65% of this cost due to death and 35% due to illness in those of working age. The cost of informal care for people with CHD in the UK was around £1.8 billion in 2006. In contrast two thirds of the production losses for stroke were due to illnesses in those of working age, and the cost of informal care (£2.9 billion) was far higher than for CHD.
Total costs
Overall CVD is estimated to cost the UK economy £30.7 billion a year. Of the total cost of CVD to the UK, around 47% is due to direct health care costs, 27% to productivity losses, and 26% to the informal care of people with CVD.
Overall CHD is estimated to cost the UK economy nearly £9.0 billion a year. Of the total cost of CHD to the UK, around 36% is due to direct health care costs, 43% to productivity losses, and 21% to the informal care of people with CHD.